Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Published January 2008 | Forecasts through 2013
Global Markets for Neonatal/Perinatal Monitoring and Treatment Products
Reports Graph
Overview
According to this report, the $1.2 billion 2008 global market for products used to monitor and treat neonatal and perinatal patients will grow at a CAGR of 5.2% reaching over $1.5 billion by 2013.

Growth in Asia-Pacific and other international markets will be driven by expanding populations and increasing birth rates, greater demand for these products, and the growing availability of low-cost or locally manufactured technologies. Developing countries account for the vast majority of annual births and preterm infants, which are at risk for developing conditions requiring ventilation, warming therapy, jaundice management, and neonatal monitoring. Driven by a growing middle class, demand is increasing for these products, which are well-established in the developed markets of the U.S., Western Europe, and Japan. The growing availability of low-cost and locally manufactured products will continue to drive sales of new units in these countries.

Sales growth will be relatively flat in the U.S. and Europe through 2013. Revenues will be driven by replacement technologies and accessories, and hospitals will continue to prefer devices that offer multiple functions. In infant ventilation, sales will increasingly shift towards comprehensive units capable of treating a full range of patients including neonatal, pediatric, and adult patients. Hybrid warming devices that can be configured as either open warmers or closed incubators will also be preferred. Specialty products such as high-frequency ventilators will also see strong sales growth through 2013. Homecare will represent a growing source for sales of monitoring and jaundice management products.

This report includes coverage of infant ventilation, infant warming, jaundice management, and monitoring products in the U.S., European, Asia-Pacific, and Rest-of-World (ROW) markets. Featured companies include Atom Medical, Draeger Medical, Fisher & Paykel Healthcare, GE Healthcare, Maquet (Getinge), Respironics (Philips Healthcare), Spacelabs Healthcare (OSI Systems), and Viasys (Cardinal Health), amongst others.
Buy Neurovascular Devices for
Hemorrhagic Stroke Market Snapshot
Companies Covered
AirShields
Analogic
Aragona Medical
Atom Medical
Bionet
Bistos
Card Guard Scientific Survival
CAS Medical Systems
Choongwae Medical
Clinical Innovations
Datascope
DatexOhmeda
Draeger Medical
Edan Instruments
eVent Medical
Fisher & Paykel Healthcare
Fukuda Denshi
GE Healthcare
Huntleigh Healthcare (Getinge)
International Biomedical
Kendall/Covidien
LMT (Lammers Medical Technology)
Lumitex
Maquet (Getinge)
Medela
Medical Select
Medix I.C.S.A.
Natus Medical
Philips Healthcare
Phoenix Medical Systems
Physician Engineered Products
Quest Medical
Respironics (Philips Healthcare)
Spacelabs Medical
Toitu
Utah Medical Products
Viasys (Cardinal Health)
Welch Allyn

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next